Canaccord Genuity sets LB Pharmaceuticals price target at $65
Canaccord Genuity announced a $65.00 per-share price target for LB Pharmaceuticals, as cited in Benzinga’s ratings-action roundup.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.